Gainers
- Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.
- Biotricity, Inc. (NASDAQ: BTCY) gained 26.3% to $1.20.
- Snow Lake Resources Ltd. (NASDAQ: LITM) surged 26.3% to $2.59.
- Amprius Technologies, Inc. (NASDAQ: AMPX) jumped 22.8% to $11.60. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
- Rockley Photonics Holdings Limited (NYSE: RKLY) gained 20.5% to $0.6287.
- Veris Residential, Inc. (NYSE: VRE) climbed 20.2% to $14.93 after Kushner Companies made an offer to acquire the company for $16 per share.
- Huadi International Group Co., Ltd. (NASDAQ: HUDI) surged 19.3% to $37.14.
- Kaleyra, Inc. (NYSE: KLR) gained 18.9% to $0.8205.
- Enservco Corporation (NYSE: ENSV) surged 18.3% to $1.74.
- Intelligent Living Application Group Inc. (NASDAQ: ILAG) gained 17.1% to $2.7518.
- The Boston Beer Company, Inc. (NYSE: SAM) surged 16.8% to $392.48 after the company reported better-than-expected Q3 adjusted EPS and sales results
- uCloudlink Group Inc. (NASDAQ: UCL) gained 13.8% to $0.6801.
- Super League Gaming, Inc. (NASDAQ: SLGG) surged 13.5% to $0.7040.
- Hawaiian Holdings, Inc. (NASDAQ: HA) shares climbed 12.3% to $15.81. Hawaiian Airlines announced an agreement with Amazon (NASDAQ:AMZN) to operate freighter aircraft.
- Pennsylvania Real Estate Investment Trust (NYSE: PEI) gained 12.2% to $2.9750.
- FedNat Holding Company (NASDAQ: FNHC) rose 11.2% to $0.6219 after dipping over 8% on Thursday.
- Novavax, Inc. (NASDAQ: NVAX) climbed 11.1% to $19.09 in sympathy with Pfizer (NYSE:PFE), which is reportedly thinking about increasing the price for COVID-19 boosters.
- Piedmont Lithium Inc. (NASDAQ: PLL) gained 11% to $59.46.
- BioNTech SE (NASDAQ: BNTX) gained 9.9% to $130.18 following reports suggesting vaccine makers could possibly raise the prices of COVID-19 shots.
- Moderna (NASDAQ:MRNA), Inc. (NASDAQ: MRNA) jumped 9.8% to $130.05 after SVB Leerink upgraded the stock from Underperform to Market Perform and raised the price target from $74 to $101.
- Energy Focus, Inc (NASDAQ: EFOI) shares gained 9.1% to $0.4399. Energy Focus, last month, named Lesley Matt as CEO.
- Schlumberger (NYSE:SLB) Limited (NYSE: SLB) surged 8.9% to $49.77 following upbeat quarterly earnings.
- Calliditas Therapeutics AB (NASDAQ: CALT) rose 8.3% to $12.45 after dipping 15% on Thursday.
- Huntington Bancshares Incorporated (NASDAQ: NASDAQ:HBAN) surged 8.2% to $14.28 after the company reported better-than-expected Q3 EPS results.
- Statera Biopharma, Inc. (NASDAQ: STAB) gained 7.6% to $0.1649. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Immunic, Inc. (NASDAQ: IMUX) shares dipped 75.3% to $2.2750 after the company reported the pre-planned Phase 1b interim analysis of IMU-935 in psoriasis patients was confounded by a high placebo rate. Two active arms did not separate from the placebo.
- NextPlay Technologies, Inc. (NASDAQ: NXTP) declined 30% to $0.2898. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
- Tenet Healthcare Corporation (NYSE: NYSE:THC) dipped 30.4% to $37.78 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
- Snap Inc . (NYSE: NYSE:SNAP) dropped 30.3% to $7.53 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
- Kala Pharmaceuticals, Inc. (NASDAQ: KALA) fell 23.5% to $7.65. Kala Pharmaceuticals announced a 1-for-50 reverse stock split.
- Sientra, Inc. (NASDAQ: SIEN) fell 23.3% to $0.3027. Sientra recently announced a proposed public offering.
- Kalera Public Limited Company (NASDAQ: KAL) dropped 22.3% to $0.3184.
- SenesTech, Inc. (NASDAQ: SNES) shares fell 21.8% to $0.2191 after declining around 18% on Thursday.
- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) dipped 21.3% to $3.0950.
- SVB Financial Group (NASDAQ: SIVB) fell 20.5% to $240.49 after reporting Q3 earnings.
- Starry Group Holdings, Inc. (NYSE: STRY) declined 20% to $0.8805. Starry announced a 50% workforce reduction and withdrew FY22 guidance.
- SVB Financial Group (NASDAQ: SIVB) dropped 19.8% to $242.57 after the company reported Q3 earnings results. Following earnings, multiple firms downgraded the stock.
- COMSovereign Holding Corp. (NASDAQ: COMS) declined 19.6% to $0.0807.
- Quanergy Systems, Inc. (NYSE: QNGY) fell 19% to $1.53.
- 9 Meters Biopharma, Inc. (NASDAQ: NMTR) declined 18.2% to $2.2006.
- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) dropped 18% to $4.1947.
- Community Health Systems, Inc. (NYSE: CYH) dipped 15.3% to $2.0150.
- Bit Origin Ltd (NASDAQ: BTOG) fell 15% to $0.2720.
- Katapult Holdings, Inc. (NASDAQ: KPLT) dropped 14.3% to $0.9430.
- NLS Pharmaceutics AG (NASDAQ: NLSP) dipped 13.7% to $0.47.
- Surgery Partners, Inc. (NYSE: SGRY) dropped 12.6% to $22.97.
- Robert Half International Inc. (NYSE: NYSE:RHI) shares fell 10.1% to $71.78 after reporting downbeat Q3 earnings.
- Zovio Inc (NASDAQ: ZVO) fell 9.2% to $0.1772 after declining 7% on Thursday.
- HCA (NYSE:HCA) Healthcare, Inc. (NYSE: HCA) dropped 9.2% to $189.50 after the company reported worse-than-expected Q3 sales results.
- Select Medical Holdings Corporation (NYSE: SEM) declined 8.3% to $21.62.
- Pinterest (NYSE:PINS), Inc. (NYSE: PINS) fell 7.1% to $21.35 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
- Twitter, Inc. (NYSE: TWTR) shares fell 4.3% to $50.18. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.